Webinar Availalbe On-Demand – Experts Share Real World Insights
By: Eric Luyer, Market Research Analyst
According to the FDA, when it comes to 3D printing, you might say that the future is already here. Due to its versatility, the agency is evaluating the applications of 3D printing in devices, drugs and biologics and to medical applications across the entire ecosystem.
- Thomas Marchand, Co-Founder & CEO of BIOMODEX provided the industry perspective
- Jenny Chen, a trained neuro-radiologist and founder/CEO of 3DHEALS, shared the physician’s perspective
- Stavros Stefanis, leader in Deloitte’s Product Development practice, shared insights on the use of 3D printing across the product development lifecycle
The webinar was held on September 28th and sponsored by Dassault Systèmes (3DS).
3D printing in Life-Sciences is NOT Science Fiction, it is Science FACT
To date, FDA has cleared over 85 applications for 3D-printed medical devices which span across many product lines such as prosthetics and implants and last year, FDA approved the first 3D printed Drug – Aprecia’s Spritam. Continue reading